David D. Allen is Dean of the University of Mississippi’s School of Pharmacy and Executive Director and Research Professor of the Research Institute of Pharmaceutical Sciences at UM. Before joining Ole Miss, he was the founding Dean of Pharmacy and Professor of Pharmaceutical Sciences at the Northeast Ohio Medical University College of Pharmacy. He is the author of 73 peer-reviewed articles and 41 professional publications, and he has contributed to four books. The recipient of dozens of leadership, teaching, research and practice awards, Allen was designated a Fellow of the American Pharmacists Association in 2011 and the American Society of Health-System Pharmacists in 2004.
Bob Blouin received his PharmD at the College and is R#53 in UK HealthCare’s Pharmacy Residency program. Dr. Blouin is the Dean and Vaughn and Nancy Bryson Distinguished Professor of the UNC Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill. Prior to his appointment as Dean, he was a long-time faculty member and administrator at the UK College of Pharmacy. Dr. Blouin is considered one of the most successful and influential leaders in pharmacy.
Kim L.R. Brouwer received her PharmD and PhD from the College, and is the William R. Kenan Jr. Distinguished Professor and Associate Dean for Research and Graduate Studies at the UNC Eshelman School of Pharmacy. A prolific researcher, Dr. Brouwer has mentored more than 85 undergraduate, graduate and postdoctoral students and published more than 295 research papers, abstracts and book chapters. She is a co-inventor of B-CLEAR®, an in vitro method to assess hepatic uptake, excretion, and biliary clearance that correlates with in vivo data.
Mary H.H. Ensom received both her bachelor’s and PharmD degrees from the UK College of Pharmacy. Dr. Ensom is Professor and Clinical Pharmacy Specialist at the University of British Columbia and Children’s & Women’s Health Centre of British Columbia. She is a prolific researcher in clinical pharmacokinetics and pharmacodynamics, with 502 publications to her credit. She has received more than 75 awards for scholarship, research, and service, including 10 outstanding teacher awards. She is one of only 34 Distinguished University Scholars at UBC.
William K. Fleming received both his bachelor and PharmD degree from the UK College of Pharmacy and now serves as Segment Vice President for Humana Inc. and President of Humana Pharmacy Solutions, where he is responsible for Humana’s pharmacy operations and business strategy that services all Humana segments, including its non-Humana membership. Dr. Fleming has spent the majority of his pharmacy career pioneering Humana’s pharmacy business.
Dr. Trish Freeman has committed her career to improving the practice of pharmacy in Kentucky and across the nation. No matter the project or program, she has consistently done one thing: Put the patient first.
From the rolling fields of Shelbyville to the big pharma and big biotech board rooms on the Pacific Coast, Carol Giltner Gallagher has had a front row seat to some of the most dynamic changes in the pharmaceutical industry over the past two decades.
Dr. Gallagher is now a Partner at New Enterprise Associates, a diversified venture capital firm that invests in healthcare and high tech companies. She focuses on investing in companies that are developing therapeutics.
Lisa Lawson received her PharmD from the UK College of Pharmacy and completed her residency with UK HealthCare. She is the first woman Dean at the Philadelphia College of Pharmacy, the oldest school of pharmacy in the nation, and a national leader in women’s health and leadership.
Phil Mayer received his bachelor’s and PhD degrees from the College. Following an academic career at the Purdue University School of Pharmacy, Dr. Mayer joined the pharmaceutical industry in 1987. He was Manager of Pharmacokinetics/Drug Metabolism at Alcon Laboratories and Department Head of Pharmacokinetics Research at Lederle Laboratories. He came to Wyeth through a corporate merger in 1995 and retired from Pfizer as Assistant Vice President of Clinical Pharmacology from in 2011. Dr. Mayer was President of the American Association of Pharmaceutical Scientists (AAPS) in 2011.
Robert Rapp earned his bachelor’s and PharmD degrees from the UK College of Pharmacy and is Professor Emeritus in the Colleges of Pharmacy and Medicine at UK. He is a global authority in the fields of infectious diseases and microbiology, having authored more than 225 peer-reviewed articles and numerous textbook chapters. Dr. Rapp remains an active consultant and is a frequently invited national and international speaker on antimicrobial stewardship programs, and antimicrobial resistance issues in hospitals, and quality assurance in parenteral drug therapy.
Salomon Stavchansky received his PhD in Pharmaceutical Sciences from the UK College of Pharmacy, and is the Alcon Centennial Professor at the University of Texas. Dr. Stavchansky has directed and participated in research concerning: the development of analytical methodology for the measurement of drugs in biological fluids, the absorption, metabolism, distribution, and elimination of drugs from biological fluids in animals and man, and the evaluation and design of drug delivery systems. His pioneering work has resulted in over 150 publications, more than 270 national and international presentations, and two book chapters.
To our alumni and friends, we’d love to hear where your career has taken you.
The UK College of Pharmacy has created a new program to honor and recognize alumni who have made exceptional contributions to the field of pharmacy during their careers. Called the Hall of Distinguished Alumni, this lifetime achievement award will be presented each year to deserving members of the pharmacy family.